Current concepts in diet and prostate cancer

Aging Health

Volumn 4, Issue 5, 2008, Pages 495-505

  Silberstein, Jonathan ^a   Parsons, J Kellogg ^a,b,c  

^a UCSD MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

carotene; Calcium; Cruciferous vegetables; Diet; Green tea; Lycopene; Meat; Pomegranate; Prostate cancer; Selenium; Soy; Vitamin D; Vitamin E; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CALCIUM; CURCUMA LONGA EXTRACT; GREEN TEA EXTRACT; ISOFLAVONE; LYCOPENE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SELENIUM; SILYMARIN; VITAMIN D; ZINC;

ANTIOXIDANT ACTIVITY; CANCER RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRUCIFERA; DAIRY PRODUCT; DIET THERAPY; DIETARY INTAKE; FAT INTAKE; HUMAN; LINSEED; MALE; MEAT; MONOTHERAPY; NUTRITIONAL STATUS; NUTRITIONAL VALUE; POMEGRANATE JUICE; PROSTATE CANCER; REVIEW; RISK REDUCTION; SOYBEAN; TOMATO; VEGETABLE;

EID: 53249095652     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.4.5.495     Document Type: Review

References (92)

1. Quinn M, Babb P: Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int. 90(2), 174-184 (2002).
2. Saigal CS, Litwin MS: The economic costs of early stage prostate cancer. Pharmacocconomics 20(13), 869-878 (2002).
3. Campbell JK, Canene-Adams K, Lindshieki BL, Boiieau TW Clinton SK, Erdman JW Jr: Tomato phytochemicals and prostate cancer risk. J. Nutr. 134(Suppl. 12), S3486-S3492 (2004).
4. Matos HR, Capelozzi VL, Gomes OF, Mascio PD, Medeiros MH: Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate. Arch. Biochem. Biophys. 396(2), 171-177 (2001).
5. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Coiditz GA, Willett WC: Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl Cancer Inst. 87(23), 1767-1776 (1995).
6. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC: A prospective study of tomato products, lycopene. and prostate cancer risk. J. Natl Cancer Inst. 94(5), 391-398 (2002).
7. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC: Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J. Cancer 121(7), 1571-1578 (2007).
8. Kirsh VA, Mayne ST, Peters U et al.: A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 15(1), 92-98 (2006).
9. Kavanaugh CJ, Trumbo, PR, Ellwood KC: The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J. Natl Cancer Inst. 99(14), 1074-1085 (2007).
10. Etminan M, Takkouche B, Caamano-Isorna F: The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol. Biomarkers Prev. 13(3), 340-35 (2004).
11. Stacewicz-Sapuntokis M, Bowen PE: Role of lycopene and tomato products in prostate health. Biochim. Biophys. Acta. 1740(2), 202-5 (2005).
12. Kucuk O, Sarkar FH, Djuric Z et al.: Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol. Med. (Maywood) 227(10), 881-885 (2002).
13. Perabo, FG, Von Law EC, Ellinger J, von Rucker A, Muller SC, Bastian PJ: Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Pnwratic Dis. 11(1), 6-12 (2008).
14. Hamilton-Reeves, JM, Rebeiio SA, Thomas W, Slaton JW, Kurzer MS: Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-β expression or serum hormonal profiles in men at high risk of prostate cancer. J. Nutr. 137(7), 1769-1775 (2007).
15. Von Low EC, Perabo FG, Siener R, Muller SC: Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In vivo 21(2), 189-204 (2007).
16. Ouchi H, Ishiguru H. Ikeda N, Hod M, Kubota Y, Uemura H: Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity. Int. J. Urol. 12(1), 73-80 (2005).
17. Jacobsen BK, Knutsen SF, Fraser GE: Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (Unned States). Cancer Causer Control 9(6), 553-557 (1998).
18. Yan L, Spitznagel EL: Meta-analysis of soy food and risk of prostate cancer in men. Int. J. Cancer 117(4), 667-669 (2005).
19. Kumar NB, Cantor A, Allen K et al.: The specific role of isoflavones in reducing prostate cancer risk. Prostate 59(2), 141-147 (2004).
20. deVere White RW, Hackman RM, Soares SE, Beckett LA, Li Y, Sun B: Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology 63(2), 259-263 (2004).
21. Dalais FS, Meliala A, Wattanapenpaiboon N et al.: Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 64(3), 510-515 (2004).
22. Schroder FH. Roobol MJ, Boeve ER et al.: Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol. 48(6). 922-930; discussion 30-31 (2005).
23. Grainger EM, Schwartz SJ, Wang S et al.: A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr. Cancer 60(2), 145-154 (2008).
24. Aggarwal BB, Ichikawa H: Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4(9), 1201-1215 (2005).
25. Brooks JD, Paton V: Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent. Prostate Cancer Prostatic Dis. 2(S3), S8 (1999).
26. Brooks JD, Paton VG, Vidanes G: Potent induction of Phase 2 enzymes in human prostate cells by suLfbraphane. Cancer Epidemiol. Biomarkers Prev. 10(9), 949-954 (2001).
27. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 25(1), 83-90 (2004).
28. Caruso AJ, Yegnasubramanian S, Lin X Kesler TW, Nelson WG: Hot water extracts from broccoli sprouts trigger induction of carcinogen-detoxification enzymes in prostate tissues. Presented at: The American Azociation for Cancer Research 95th Annual Meeting. Orlando, FL, USA 729 (2004).
29. Canene-Adams K, Lindshield BL, Wang S. Jeffery EH, Clinton SK, Erdman JW Jr: Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res. 67(2), 836-843 (2007).
30. Kirsh VA, Peters U, Mayne ST et al.: Prospective study of fruit and vegetable intake and risk of prostate cancer. J. Natl Cancer Inst. 99(15), 1200-1209 (2007).
31. Giovannucci E, Rimm EB, Liu Y. Stampfer MJ, Willett WC: A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 12(12), 1403-1409 (2003).
32. Key TJ, Allen N. Appleby P et al.: Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 109(1), 119-124 (2001).
33. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ et al.: Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 174(3), 1065-1069; discussion 9-70 (2005).
34. Ornish D, Magbanua MJ, Weidner G et al.: Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc. Natl Acad. Sci. USA 105(24), 8369-8374 (2008).
35. Parsons JK, Newman V, Mohler JL, Pierce JP, Paskett E, Marshall J: The Men's Eating and Living (MEAL) Study: a cancer and leuken-da group B pilot trial of dietary intervention for the treatment of prostate. Cancer Urology 72(3), 633-637 (2008).
36. Cheung E. Wadhera P, Dorff T, Pinski J: Diet and prostate cancer risk reduction. Expert Rev. Anticancer Ther. 8(1), 43-50 (2008).
37. Crispen PL, Uzzo, RG, Golovine K et al.: Vitamin E succinate inhibits NF-κB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention, Prostate 67(6), 582-590 (2007).
38. Venkateswaran V, Fleshner NE, Klotz LH: Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J. Urol. 168(4 Pt 1), 1578-1582 (2002).
39. Shiau CW, Huang JW, Wang DS et al.: α-tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function. J. Biol. Chem. 281(17), 11819-11825 (2006).
40. Heinonen OP, Albanes D, Virtamo J et al.: Prostate cancer and supplementation with alpha-tocopherol and β-carotene: incidence and mortality in a controlled trial. J. Natl Cancer Inst. 90(6), 440-446 (1998).
41. Chan JM, Stampfer MJ, Ma J. Rimm EB, Willett WC, Giovannucci EL: Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol. Biomarkers Prev. 8(10), 893-899 (1999).
42. Kirsh VA, Hayes RB, Mayne ST et al.: Supplemental and dietary vitarnin E, β-carotene, and vitamin C intakes and prostate cancer risk. J. Natl Cancer Inst. 98(4), 245-254 (2006).
43. Wright ME, Weinstein SJ, Lawson KA et al.: Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol. Biomarkers Prev. 16(6), 1128-11235 (2007).
44. Lippman, SM, Goodman PJ, Klein EA et al.: Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Natl. Cancer Inst. 97(2), 94-102 (2005).
45. Yamaguchi K, Uzzo RG, Pimkina J et al.: Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene 24(38), 5868-5877 (2005).
46. Lee SO, Yeon Chun J, Nadiminty N et al.: Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 66(10), 1070-1075 (2006).
47. Clark LC, Combs GF Jr, Tumbull BW et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276(24), 1957-1963 (1996).
48. Duffield-Lillico AJ, Slate EH, Reid ME et al.: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J. Natl Cancer Inst. 95(19), 1477-1481 (2003).
49. Etminan M, FitzGerald JM, Gleave M, Chambers K: Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16(9), 1125-1131 (2005).
50. Syed DN, Khan N. Afaq F, Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol. Biomarkers Prev. 16(11), 2193-2203 (2007).
51. Ingraham BA, Bragdon B, Nohe A: Molecular basis of the potential of vitamin D to prevent cancer, Curr. Med. Res. Opin 24(1), 139-149 (2008).
52. Colli JL, Colli A: International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol. Oncol. 24(3), 184-194 (2006).
53. Schwartz GG, Hanchette CL: UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control 17(8), 1091-1101 (2006).
54. Vieth R, Choo R, Deboer L, Danjoux C, Morton GC, Klotz L: Rise in prostate-specific antigen in men with untreated low-grade prostate cancer is slower during spring-summer. Am. J. Ther. 13(5), 394-399 (2006).
55. Tavani A, Bertuccio P, Bosetti C et al.: Dietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancer. Eur. Urol. 48(1), 27-33 (2005).
56. Ahn J, Peters U, Albanes D et al.: Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J. Natl Cancer Inst. 100(11), 796-804 (2008).
57. Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J. Clin. Oncol. 23(32), 8152-8160 (2005).
58. Giovannucci E, Liu Y, Rimin EB et al.: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98(7), 451-459 (2006).
59. Williams AW, Boileau TW, Zhou JR, Clinton SK, Erdman JW Jr: β-carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J. Nutr. 130(4), 728-732 (2000).
60. Key TJ, Appleby PN, Allen NE et al.: Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study Am. J. Clin. Nutr. 86(3), 672-681 (2007).
61. Virtamo J. Pietinen P, Huttunen JK et al.: Incidence of cancer and mortality following alpha-tocopherol and β-carotene supplementation: a postintervention follow-up. JAMA 290(4), 476-485 (2003).
62. Hennekens CH, Buring JE, Manson JE et al.: Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334(18), 1145-1149 (1996).
63. Cook NR, Stampfer MJ, Ma J et al.: β-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 86(9), 1783-1792 (1999).
64. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H: Beneficial effects of tea and its polyphenols against prostate cancer. Mol. Nutr. Food Res. 50(2), 130-143 (2006).
65. Yang CS, Lambert JD, Ju J, Lu G, Sang S: Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol. Appl. Pharmacol. 224(3), 265-273 (2007).
66. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S: Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol. 167(1), 71-77 (2008).
67. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H: Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl Acad. Sci. USA 102(41), 14813-14818 (2005).
68. Sartippour MR, Seeram NP, Rao JY et al.: Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int. J. Oncol. 32(2), 475-480 (2008).
69. Hong MY, Seeram, NP, Heber D: Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J. Nutr. Biochem. (2008) (Epub ahead of print).
70. Pantuck AJ, Leppert JT, Zomorodian N et al.: Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin. Cancer Res. 12(13), 4018-4026 (2006).
71. Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA: Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer 86(6). 1019-1027 (1999).
72. Fleshner N, Zlotta AR: Prostate cancer prevention: past, present, and future. Cancer 110(9), 1889-1899 (2007).
73. Fleshner N, Bagnell PS, Klotz L, Venkateswaran V: Dietary fat and prostate cancer. J. Urol. 171(2 Pt 2), S19-S24 (2004).
74. Rodriguez C, McCullough ML, Mondul AM et al.: Meat consumption among black prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 15(2), 211-216 (2006).
75. Crowe FL, Key TJ, Appleby PN et al.: Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 87(5), 1405-1413 (2008).
76. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel IN: Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int. J. Cancer 121(6), 1339-1345 (2007).
77. Rodriguez C, Freedland SJ, Deka A et al.: Body mass index, weig~t change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 16(1), 63-69 (2006).
78. Demark-Wahnefried W, Price DT, Polascik TJ et al.: Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58(1), 47-52 (2001).
79. Shike M, Latkany L, Riedel E et al.: Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. J. Clin. Oncol. 20(17), 3592-3598 (2002).
80. Holmes MD, Pollak MN, Willett WC, Hankinson SE: Dietary correlates of plasma insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev. 11(9), 852-861 (2002).
81. Giovannucci E: Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9(6), 567-582 (1998).
82. Gao X, LaValley MP, Tucker KL: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J. Natl Cancer Inst. 97(23), 1768-1777 (2005).
83. Giovannucci E, Liu Y, Stampfer MJ. Willett WC: A prospective study of calcium intake and incident and fatal prostate cancer.Cancer Epidemiol. Biomarkers Prev. 15(2), 203-210 (2006).
84. Ahn J, Albanes D. Peters U, Schatzkin A, Lim U, Freedman M et al.: Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 16(12), 2623-2630 (2007).
85. Mitrou PN, Albanes D, Weinstein SJ et al.: A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int. J. Cancer 120(11), 2466-2473 (2007).
86. Welten DC, Kemper HC, Post GB, van Staveren WA: A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J. Nutr. 125(11), 2802-2813 (1995).
87. Cho E, Smith-Warner SA, Spiegelman D et al.: Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J. Natl Cancer Inst. 96(13), 1015-1022 (2004).
88. Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS: HIF-1alpha promotes survival of prostate cells at a high zinc environment. Prostate 67(14), 1514-1523 (2007).
89. Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL: Zinc supplement use and risk of prostate cancer. J. Natl Cancer Inst. 95(13), 1004-1007 (2003).
90. Lawson KA, Wright ME, Subar A et al.: Multivitamin use and risk of prostate cancer in the National Institutes of Heatth-AARP Diet and Health Study. J. Natl Cancer Inst. 99(10), 754-764 (2007).
91. Doyle C, Kushi LH, Byers T et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J. Clin. 56(6), 323-353 (2006).
92. Parsons JK, Newman VA, Mohler JL, Pierre JP, Flatt S, Marshall J: Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study. BJU Int. DOI: 10.1111/j.1464-410X.2007.07365.x (2008).